RNU6-75P

Across TCGA pan-cancer cohorts, RNU6-75P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-75P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-75P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-75P expression acts as an unfavorable survival marker.

ESCA, BLCA, and KIRC are the cancer types where RNU6-75P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.464	0.907	<.001	72	view →
BLCA	DFS	Tertile	All	0.220	0.620	<.001	54	view →
KIRC	DFS	Tertile	III,IV	0.277	0.656	.005	48	view →
LUSC	OS	Tertile	II,III,IV	0.417	0.749	.003	36	view →
COAD	OS	Tertile	All	0.206	0.571	.023	27	view →
STAD	DFS	Tertile	All	0.449	0.726	.018	18	view →
UCEC	DFS	Tertile	All	0.148	0.650	.028	12	view →
LUAD	OS	Tertile	II,III,IV	0.222	0.676	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-75P–ESCA (OS)

Open the ESCA breakdown →